Resumen de negocios
Número de empleados: 376
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21/11/22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/03/22 | |
Chief Tech/Sci/R&D Officer | - | 03/02/20 | |
David Biddell
PRN | Corporate Officer/Principal | - | - |
Leon J. Atencia
PRN | Corporate Officer/Principal | - | 15/07/21 |
Evan Hockman
SAM | Sales & Marketing | - | - |
Wanda Francies
HRO | Human Resources Officer | - | - |
Kenji Aso
PRN | Corporate Officer/Principal | - | - |
Gerry McKenzie
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21/11/22 |
Chairman | 57 | 21/11/22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21/11/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 49 417 407 | 49 245 119 ( 99,65 %) | 0 | 99,65 % |
Información de la empresa
Aerie Pharmaceuticals, Inc.
6201 South Freeway
76134, Forth Worth
+919 237 5300
http://www.aeriepharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 653 mil M | |
+27,00 % | 556 mil M | |
-6,76 % | 354 mil M | |
+20,34 % | 331 mil M | |
+3,00 % | 296 mil M | |
+13,09 % | 233 mil M | |
+5,46 % | 201 mil M | |
-9,61 % | 193 mil M | |
-6,26 % | 144 mil M |